Targeting Phage Therapy 2023: Concluding Remarks & What’s Next
The 6th World Congress on Targeting Phage Therapy 2023 was successfully held on June 1-2, 2023 in Paris. It gathered more than 150 attendees from 30+ different countries, and included 71+ communications. Targeting Phage Therapy 2023 discussed all aspects related to phages and phage therapy. Photo Gallery of Targeting Phage Therapy 2023
You can access more photos in the Targeting Phage Therapy 2023 photo gallery and learn more about the conference experience.
Targeting Phage Therapy 2023: Replay & Abstracts Book
Who Attended Targeting Phage Therapy 2023?
Industrial participants:
PHIOGEN (USA)
Armata Pharmaceuticals (USA)
BiomX (Israel)
Acteryon (Poland)
Cellexus (UK)
Adaptive Phage Therapeutics (USA)
Aparon (UK)
AusHealth (Australia)
Biochimpharm JSC (Georgia)
BIOCODEX (Paris)
BIOMERIEUX SA (France)
COBIK (Slovenia)
ERYTECH Pharma (France)
H Venture Partners (USA)
H Ventures (USA)
Intralytix, Inc. (USA)
Jafral (Slovenia)
MB Pharma s.r.o. (Czech Republic)
Microbiotix Inc. (USA)
Optipharm Inc. (Republic of Korea)
Phage Consulting
Phages2Patients (Germany)
Phagos (France)
Pherecydes Pharma (France)
Proteon Pharmaceuticals S.A. (Poland)
R.E.D. Laboratories (Belgium)
Resistell (Switzerland)
Rime Bioinformatics (France)
Sanofi (USA)
SET Medikal (Turkey)
TechnoPhage (Poland)
Tillotts Pharma AG (Switzerland)
Vésale Bioscience (Belgium)
Vetoquinol (France)
Vitalis Phage Therapy (India)
Academic participants:
Adam Mickiewicz University, Agricultural University of Athens, Amrita Universit, Armata Therapeutics, Azabu University, Bacteriophage.news, Baylor College of Medicine, Bhabha Atomic Research Centre, Biological Research Centre, Szeged, Campus Universitaire de Maubeuge, Centre International de Recherche en Infectiologie, Chungnam Natl. Univ., Comenius University, Communicable Diseases Institute, Consejo Superior de Investigaciones Científicas, Corpo De Bombeiros Militar Do Amazonas,Corpo De Bombeiros Militar Do Amazonas / Fundação Universidade Aberta Da Terceira Idade, CY Paris Cergy Université, Department of Veterinary Medicine, Institute of Pharmacology and Toxicology, Free University Berlin, Deutsches Zentrum für Infektionsforschung, ENS de Lyon, Eötvös Loránd University, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Food and Drug Administration (FDA), Fundação Universidade Aberta Da Terceira, Fundación AZTI, G. Eliava Institute of Bacteriophages, microbiology and virology ,Geneva University Hospital, German Center for Infection Research (DZIF),German Federal Institute for Risk Assessment, Helmholtz Center Munich, Hirszfeld Institute of Immunology and Experimental Therapy, Hôpitaux Unversitaires de Genève,Hospices Civils de Lyon, Ilia State University, INSERM, Institut Pasteur, Instituto de Biología Integrativa de Sistemas (I2SysBio) Universitat de València-CSIC, Israel Institute for Biological Research,Istanbul University, Istinye University, Jomo Kenyatta University of Agriculture and Technology, Khon Kaen University, Korea Advanced Institute of Science and Technology, KU Leuven, Kyorin University, Laboratoire ERRMECe, Laboratoire M2iSH, Lesaffre International, Louvain University, Masaryk University, Max Planck Institute for Medical Research, Medical center Francesc Macia, MPI, National Taiwan University, North-West Unversity, Pediatric Infectious Diseases Research Center, Phage Consulting, Phage Directory, Pharmabiotic Research Institute (PRI), Polish Academy of Sciences…